BioWorld MedTech

May 14, 2015

Financings: Glaukos files IPO, could be first public company in MIGS space

The latest development in the minimally invasive glaucoma surgical (MIGS) space comes from Glaukos (Laguna Hills, California) as the company has reportedly filed for an initial public offering (IPO) to raise $86 million. Read More

HRS annual Meeting : EP; HRS in danger of losing seat at the AMA RUC table

PLAC build-up: Cardio diagnostics broadening

Take a moment to complete critical reader survey

ResMed Fails to Hold SERVE: ResMed stock down after SERVE-HF misses its primary endpoint

Agreements/contracts: Abbott, GE Healthcare to integrate electrogram data

World in Review: W.L. Gore registers Excluder endoprosthesis in Australia

Patent Watch: USPTO issues patent allowance for Rosetta Cancer Origin Test

Briefly Noted

Product briefs

People in Places

MDD's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Illustration of brain and brain waves, concept of focal seizure

Hyperexcitability may be joint problem in epilepsy, dementia

BioWorld

The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...